News for '-us-food'

'Famotidine may become the next HCQ for Covid-19'

'Famotidine may become the next HCQ for Covid-19'

Rediff.com10 May 2020

Researchers at Northwell Health in New York are testing the effects on Famotidine (used in high intravenous doses) on Covid-19 patients as a potential treatment. After the hospital announced its clinical trials, it led to a drug shortage in the US. Back home, however, there has not been any surge in the demand for Famotidine yet.

Coronavirus crisis could stretch up to August, warns Trump

Coronavirus crisis could stretch up to August, warns Trump

Rediff.com17 Mar 2020

At least 85 people have died of coronavirus with the confirmed cases crossing 4,500 in the US.

Cadila believes it has silver bullet to fight COVID-19

Cadila believes it has silver bullet to fight COVID-19

Rediff.com21 Apr 2020

Can Interferon alfa-2b treat COVID-19 effectively?

Anti-malarial drug a 'line of defence' against virus: Trump

Anti-malarial drug a 'line of defence' against virus: Trump

Rediff.com20 May 2020

The US president said the drug has gotten a bad reputation only because 'he was promoting it'.

Ranbaxy Lab dips nearly 7% on bourses

Ranbaxy Lab dips nearly 7% on bourses

Rediff.com24 Jun 2013

As per the media report, the US Food and Drug Administration is learnt to have issued a Form 483 to the company's manufacturing facility at Mohali a few months ago after finding deviations from norms during an inspection of the plant.

Hydroxychloroquine can be fatal: Experts

Hydroxychloroquine can be fatal: Experts

Rediff.com6 May 2020

As the pandemic spreads and the urgency for effective treatment of COVID-19 mounts, several countries, including the US, have started relying heavily on HCQ, majorly used in the treatment of malaria and rheumatoid-arthritis.

7 Indian pharma players race to develop COVID-19 vaccine

7 Indian pharma players race to develop COVID-19 vaccine

Rediff.com19 Jul 2020

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.

USFDA warns Aurobindo Pharma

USFDA warns Aurobindo Pharma

Rediff.com23 May 2011

Company had earlier received an import alert in February this year from the US Food and Drug Administration.

Dr Reddy's A-team moves on putting house in order

Dr Reddy's A-team moves on putting house in order

Rediff.com10 Oct 2018

After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug Administration's warning letter on compliance issues, the company's leadership has finally set out to bring the house in order.

Why US FDA is cracking down on India's shrimp shipments

Why US FDA is cracking down on India's shrimp shipments

Rediff.com12 Feb 2019

US, the largest market for Indian shrimp exporters, is peeved over the use of banned antibiotics.

Wockhardt Q1 net profit dips 94% to Rs 19.95 crore

Wockhardt Q1 net profit dips 94% to Rs 19.95 crore

Rediff.com12 Aug 2014

The company had posted a consolidated net profit of Rs 323.31 crore (Rs 3.23 billion) in the same period last fiscal, Wockhardt Ltd said in a filing to the Bombay Stock Exchange.

A bitter pill for Aurobindo's sterile drug unit

A bitter pill for Aurobindo's sterile drug unit

Rediff.com25 Nov 2019

USFDA issues Form 483 with as many as 14 observations that could impact ongoing operations at Aurobindo's Pashamailaram facility in Hyderabad.

Gurgaon-Bihar: 8 days, 1,000 km and 11 men on 11 cycle rickshaws

Gurgaon-Bihar: 8 days, 1,000 km and 11 men on 11 cycle rickshaws

Rediff.com26 May 2020

Kumar had registered for the Shramik Special train. Everyday, he hoped his phone will ring and he will be asked to come to the station. But, only his landlord's call came everyday asking when he would pay the due rent. Dejected with the wait, Kumar decided to go to the Gurgaon Railway Station where he was refused an entry.

Rs 3,500-cr fine on Singh bros, not Rs 2,562 cr: Daiichi

Rs 3,500-cr fine on Singh bros, not Rs 2,562 cr: Daiichi

Rediff.com7 May 2016

Daiichi alleged that Singh brothers had concealed and misrepresented critical information concerning US Food and Drug Administration and Department of Justice investigations into Ranbaxy

India lifts temporary ban on supply of hydroxychloroquine

India lifts temporary ban on supply of hydroxychloroquine

Rediff.com7 Apr 2020

India on Tuesday temporarily licensed the export of paracetamol and anti-malarial drug Hydroxychloroquine in appropriate quantities to some countries, which have been particularly badly affected by the coronavirus pandemic.

Robots to the rescue in times of coronavirus

Robots to the rescue in times of coronavirus

Rediff.com19 Jul 2020

From scanning hospital entrants to disinfecting hospital areas and floors, robots are being roped in for tasks considered high-risk, says Peerzada Abrar.

Travel restrictions imposed after 1st coronavirus death in US

Travel restrictions imposed after 1st coronavirus death in US

Rediff.com1 Mar 2020

Vice President Mike Pence said Trump had authorised a ban on entry of foreign nationals who travelled to Iran in the last 14 days. The United States also advised its citizens not to travel to parts of South Korea and Italy, from where reports of coronavirus have appeared.

US races against time as COVID-19 toll crosses 10K

US races against time as COVID-19 toll crosses 10K

Rediff.com7 Apr 2020

Over 3,66,000 Americans have tested positive for the deadly coronavirus.

GSK withdraws sale of Zinetac after health alert

GSK withdraws sale of Zinetac after health alert

Rediff.com26 Sep 2019

GSK is continuing with investigations into the potential source of the NDMA, which is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.

32 stocks tide over Brexit woes, hit all-time high

32 stocks tide over Brexit woes, hit all-time high

Rediff.com1 Jul 2016

Since UK referendum outcome to exit European Union last Friday, 32 companies have hit record highs.

Policy tweaks in US shift Indian pharma's focus

Policy tweaks in US shift Indian pharma's focus

Rediff.com18 Jun 2014

As marketing rights for off-patent drugs in the US become less exclusive, companies are scrambling for fresh strategies to make up for the revenue loss.

India can deliver COVID-19 vaccine swiftly and efficiently

India can deliver COVID-19 vaccine swiftly and efficiently

Rediff.com4 Jan 2021

'Rolling out the vaccine is not a major challenge in India.'

Plasma therapy isn't proven treatment for COVID-19: Govt

Plasma therapy isn't proven treatment for COVID-19: Govt

Rediff.com29 Apr 2020

Addressing a press briefing, health ministry Joint Secretary Lav Agarwal said currently there are no approved therapies for COVID-19 and there is not enough evidence to claim that plasma therapy can be used for treatment of the disease.

Sun Pharma ends patent dispute with Actavis

Sun Pharma ends patent dispute with Actavis

Rediff.com6 Oct 2015

Ranbaxy, its partners and Actavis have signed a non-exclusive agreement.

See: Why these migrants won't come back to Mumbai

See: Why these migrants won't come back to Mumbai

Rediff.com16 May 2020

'If we don't get any bus from here, we will start walking home.' 'What else can we do?' 'We don't want to die of hunger here.'

Meet India's 10 new dollar billionaires

Meet India's 10 new dollar billionaires

Rediff.com22 Jul 2014

The number of dollar billionaires in India has risen to 55 this year from 46 last year.

Indian pharma exports report double-digit growth after 3 yrs

Indian pharma exports report double-digit growth after 3 yrs

Rediff.com3 May 2019

The only category of pharmaceuticals that showed a negative growth in exports this time was herbal products, exports of which stood at $299 million as compared to $ 312 million in the previous year.

Why US doctors want Indian drugs to be banned

Why US doctors want Indian drugs to be banned

Rediff.com24 Mar 2014

In the final part of a three-part series on America's war on substandard Indian generic drugs, Aziz Haniffa speaks about American doctors' contempt for drugs exported from India and the ineptitude of the US Food and Drug Administration to stop the menace.

USFDA bans more products from Ranbaxy

USFDA bans more products from Ranbaxy

Rediff.com24 Jan 2014

The move follows an FDA inspection of a Ranbaxy facility which identified significant violations of sound manufacturing practices.

'During the war, we reached 40 km into Pakistan'

'During the war, we reached 40 km into Pakistan'

Rediff.com16 Dec 2020

'My brave JCO managed to get to the gun, sit on top of the dead man and fired away at the attacking aircraft till they melted away into the darkness.'

Why Wockhardt's Waluj facility is under lens

Why Wockhardt's Waluj facility is under lens

Rediff.com18 Nov 2013

After recovering from issues such as defaults on foreign currency convertible bonds and piling debts, pharmaceutical major Wockhardt has been on the slow lane through the last six months, following warnings from global regulators such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare Products Regulatory Agency.

Why Ranbaxy's big setback is not yet over

Why Ranbaxy's big setback is not yet over

Rediff.com18 Sep 2013

US drug regulator's fiat on Mohali factory, after strictures on the two other major Indian units, has numerous negative implications.

Ranbaxy, JP Associates to exit Nifty from Mar 28

Ranbaxy, JP Associates to exit Nifty from Mar 28

Rediff.com27 Feb 2014

Tech Mahindra and United Spirits will replace them in the 50-share index of the National Stock Exchange with effect from March 28.

Experts welcome WHO's decision to resume HCQ clinical trial

Experts welcome WHO's decision to resume HCQ clinical trial

Rediff.com4 Jun 2020

The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.

PIL in Supreme Court for action against Ranbaxy

PIL in Supreme Court for action against Ranbaxy

Rediff.com5 Jun 2013

An advocate on Wednesday approached the Supreme Court with a PIL seeking cancellation of the license granted to Ranbaxy Laboratories and for initiating probe against the pharma major for allegedly manufacturing and selling adulterated drugs.

J&J's loss may be good news for Indian pharmas

J&J's loss may be good news for Indian pharmas

Rediff.com1 Nov 2018

Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga

Ranbaxy introduces whistle-blower policy

Ranbaxy introduces whistle-blower policy

Rediff.com27 May 2013

Patient safety and quality our guidance now, says CEO and MD Arun Sawhney.

'What's more important? Feeding people or enriching 1 person?'

'What's more important? Feeding people or enriching 1 person?'

Rediff.com22 Mar 2017

'Why should farmers who give us food be vacated to hand over their property to a private company held by one individual,' asks green activist S P Udaykumar.

Sun Pharma gets USFDA nod for anti-cancer injection

Sun Pharma gets USFDA nod for anti-cancer injection

Rediff.com5 Feb 2013

This generic Doxorubicin HCl Liposome injection USP, 2 mg/ml is therapeutically equivalent to Doxil Liposome Injection, 2 mg/ml of Janssen Research and Development, LLC.

I can stand behind every pill: Ranbaxy CEO

I can stand behind every pill: Ranbaxy CEO

Rediff.com27 May 2013

The US FDA, during its inspection of Ranbaxy's manufacturing facilities in India, between 2006 and 2008, had found violations, incomplete testing records and an inadequate stability programme, besides manufacturing practices that did not follow regulations.